Skip to main content
Fig. 1 | Infectious Agents and Cancer

Fig. 1

From: The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells

Fig. 1

Degradation of Rap1GAP is inhibited by MG132 in HPV16/18 positive cervical cancer cells. HeLa (A), SiHa (B), and C33A (C) cells were treated with 20 μmol/L MG132 for 24 h. The levels of Rap1GAP and p53 proteins were analyzed using western blotting, as described in “Methods” section. The fold change is the ratio of the value from the cells treated with MG132 divided by that from the control cells. The data are from three independent experiments. *p < 0.05

Back to article page